- Anemia in chronic kidney disease:
- EPO deficiency drives CKD anemia; exogenous EPO replaces it; over-aggressive targets bring hypertension and thrombotic risk.
- Simple extraction in a warfarin patient:
- Continue warfarin (INR in range) with local hemostasis; PT/INR vs PTT; metronidazole/azole-INR interaction.
- Aspirin and the 7-10 day platelet effect:
- Irreversible platelet COX-1 acetylation; lasts 7-10 days (platelet lifespan); usually continue for simple extractions; dual antiplatelet caveat.
- Respiratory acidosis from oversedation:
- Benzo + opioid additive depression; airway/oxygen/bag-mask first; titrate naloxone + flumazenil; renal compensation hours-days.
- DKA: high anion-gap metabolic acidosis:
- Ketoacid-driven anion-gap metabolic acidosis; Kussmaul breathing as respiratory compensation; MUDPILES differential; defer elective work.
- Malignant hyperthermia and dantrolene:
- RYR1-susceptible + succinylcholine/volatile trigger; dantrolene blocks SR Ca2+ release; supportive care (stop trigger, O2, cooling, correct K+ and pH).
- Serotonin syndrome from tramadol + SSRI:
- Tramadol SNRI + mu agonist; triad (mental + autonomic + neuromuscular); seizure threshold lowered; non-serotonergic opioids for SSRI patients.
- Immune cells, neutropenia, and chemotherapy:
- Neutrophil first-responder; ANC <500 severe neutropenia; check ANC + platelets before invasive work; B-cell antibody vs T-cell cytotoxic roles.